Renovaro Inc (RENB)
1.41
-0.08
(-5.37%)
USD |
NASDAQ |
Jun 03, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Renovaro Cash from Investing (TTM): -1.213M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -1.213M |
December 31, 2023 | -1.121M |
September 30, 2023 | -1.088M |
June 30, 2023 | -0.0298M |
March 31, 2023 | -0.0236M |
December 31, 2022 | -0.0236M |
September 30, 2022 | 0.00 |
June 30, 2022 | -0.0052M |
March 31, 2022 | -0.0433M |
December 31, 2021 | -0.0433M |
September 30, 2021 | -0.054M |
June 30, 2021 | -0.0489M |
March 31, 2021 | -0.0212M |
December 31, 2020 | -0.0629M |
September 30, 2020 | -0.1158M |
June 30, 2020 | -0.1845M |
March 31, 2020 | -0.1575M |
December 31, 2019 | -0.2084M |
September 30, 2019 | -0.4771M |
June 30, 2019 | -0.7167M |
March 31, 2019 | -1.030M |
December 31, 2018 | 3.846M |
September 30, 2018 | -0.6577M |
June 30, 2018 | -0.5757M |
Date | Value |
---|---|
March 31, 2018 | -0.4749M |
December 31, 2017 | -5.259M |
September 30, 2017 | -0.4223M |
June 30, 2017 | -0.1961M |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 1.053M |
March 31, 2016 | 3.082M |
December 31, 2015 | 1.068M |
September 30, 2015 | 1.200M |
March 31, 2015 | 0.4734M |
December 31, 2014 | -1.952M |
September 30, 2014 | 0.0755M |
June 30, 2014 | -0.0564M |
March 31, 2014 | -0.3827M |
December 31, 2013 | 0.0132M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | -0.0048M |
June 30, 2012 | -0.0132M |
March 31, 2012 | -0.0132M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.213M
Minimum
Mar 2024
--
Maximum
Sep 2022
-0.2819M
Average
-0.0585M
Median
Cash from Investing (TTM) Benchmarks
DIH Holding US Inc | -- |
AIM ImmunoTech Inc | -0.912M |
Perspective Therapeutics Inc | -48.19M |
Protalix BioTherapeutics Inc | -22.05M |
Armata Pharmaceuticals Inc | -6.374M |